Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. (Q53572738)
Jump to navigation
Jump to search
scientific article published on 5 February 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. |
scientific article published on 5 February 2007 |
Statements
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. (English)
Martin S Tallman
1 reference
Elisabeth Paietta
1 reference
John C Byrd
1 reference
Frederick R Appelbaum
1 reference
Diane F Jelinek
Michael R Grever
John G Gribben
Gordon W Dewald
Shinichi Kitada
David M Lucas
Donna S Neuberg
John C Reed
5 February 2007
25
7
799-804